Zobrazeno 1 - 10
of 61
pro vyhledávání: '"FIV vaccine"'
Autor:
Bikash Sahay, Alek M. Aranyos, Meerambika Mishra, Andrew C. McAvoy, Marcus M. Martin, Riuyu Pu, Sayaka Shiomitsu, Keijiro Shiomitsu, Michael J. Dark, Missa P. Sanou, Shannon R. Roff, Mobeen H. Rathore, Janet K. Yamamoto
Publikováno v:
Viruses, Vol 11, Iss 2, p 136 (2019)
For the development of an effective HIV-1 vaccine, evolutionarily conserved epitopes between feline and human immunodeficiency viruses (FIV and HIV-1) were determined by analyzing overlapping peptides from retroviral genomes that induced both anti-FI
Externí odkaz:
https://doaj.org/article/0b2ca80d22f247ed953a086d80df7b09
Autor:
Bikash Sahay, Janet K. Yamamoto
Publikováno v:
Viruses, Vol 10, Iss 5, p 277 (2018)
The feline immunodeficiency virus (FIV) vaccine called Fel-O-Vax® FIV is the first commercial FIV vaccine released worldwide for the use in domestic cats against global FIV subtypes (A–E). This vaccine consists of inactivated dual-subtype (A plus
Externí odkaz:
https://doaj.org/article/f9175f06da8f4c948c9400206757b1d4
Publikováno v:
Veterinary microbiology. 250
Infections with feline immunodeficiency virus (FIV) are common in New Zealand, although the impact of those infections on the health status of the cats remains unclear. Although many cats are vaccinated yearly with a commercial FIV vaccine containing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616dab65a84d97a91ca591a6b29aad49
https://pubmed.ncbi.nlm.nih.gov/33045631
https://pubmed.ncbi.nlm.nih.gov/33045631
Autor:
Keijiro Shiomitsu, Janet K. Yamamoto, Meerambika Mishra, Bikash Sahay, Alek M Aranyos, Michael J. Dark, Marcus M. Martin, Missa P Sanou, Riuyu Pu, Shannon R Roff, Mobeen H. Rathore, Sayaka Shiomitsu, Andrew C. McAvoy
Publikováno v:
Viruses
Volume 11
Issue 2
Viruses, Vol 11, Iss 2, p 136 (2019)
Volume 11
Issue 2
Viruses, Vol 11, Iss 2, p 136 (2019)
For the development of an effective HIV-1 vaccine, evolutionarily conserved epitopes between feline and human immunodeficiency viruses (FIV and HIV-1) were determined by analyzing overlapping peptides from retroviral genomes that induced both anti-FI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f086a397fcc6932dd337486fcc964198
Autor:
Brian J. Willett, Paweł M. Bęczkowski, Matthew Harris, Julia A. Beatty, Margaret J Hosie, Navapon Techakriengkrai
Publikováno v:
Vaccine
Highlights • FIV vaccinated cats screened for neutralising antibodies • Homologous neutralisation in 50% of cats tested • No heterologous neutralisation
Across human and veterinary medicine, vaccines against only two retroviral infections
Across human and veterinary medicine, vaccines against only two retroviral infections
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba1ff42d57bd77a2ac9f9023b5ed3685
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Australian veterinary journal. 97(3)
With the commercial release in Australia in 2004 of a vaccine against feline immunodeficiency virus (FIV; Fel-O-Vax FIV®), the landscape for FIV diagnostics shifted substantially. Point-of-care (PoC) antibody detection kits, which had been the mains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47536b6c9344841e065423dfd9434a68
https://pubmed.ncbi.nlm.nih.gov/31441037
https://pubmed.ncbi.nlm.nih.gov/31441037
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of the American Veterinary Medical Association. 225:1554-1557
Objective—To determine whether passive transfer of immunity affects results of diagnostic tests for antibodies against FIV in kittens born to vaccinated queens. Design—Experimental trial. Animals—12 specific-pathogen-free queens and their 55 ki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2aecb244d4fcf42353cdff66132e571
https://doi.org/10.2460/javma.2004.225.1554
https://doi.org/10.2460/javma.2004.225.1554